Investors Sell UnitedHealth Group Incorporated (UNH) on Strength (UNH)
Traders sold shares of UnitedHealth Group Incorporated (NYSE:UNH) on strength during trading on Tuesday. $84.17 million flowed into the stock on the tick-up and $160.58 million flowed out of the stock on the tick-down, for a money net flow of $76.41 million out of the stock. Of all equities tracked, UnitedHealth Group had the 9th highest net out-flow for the day. UnitedHealth Group traded up $1.19 for the day and closed at $198.63
Several research firms have recently weighed in on UNH. ValuEngine upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Cantor Fitzgerald reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Tuesday, August 29th. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 price objective on the stock in a report on Thursday, September 21st. UBS AG reiterated an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, August 24th. Finally, Morgan Stanley increased their target price on shares of UnitedHealth Group from $210.00 to $215.00 and gave the stock an “overweight” rating in a research report on Thursday, August 17th. Two investment analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $203.59.
The company has a market capitalization of $192.05 billion, a PE ratio of 23.86 and a beta of 0.63. The firm’s 50 day moving average is $195.77 and its 200-day moving average is $182.90.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, beating the Zacks’ consensus estimate of $2.38 by $0.08. The company had revenue of $50.05 billion for the quarter, compared to analysts’ expectations of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. UnitedHealth Group’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.96 earnings per share. On average, analysts expect that UnitedHealth Group Incorporated will post $9.87 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th were given a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.51%. The ex-dividend date was Thursday, September 7th. UnitedHealth Group’s dividend payout ratio is presently 35.13%.
In related news, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction that occurred on Monday, August 21st. The shares were sold at an average price of $191.71, for a total value of $2,875,650.00. Following the completion of the sale, the director now owns 1,818,898 shares in the company, valued at approximately $348,700,935.58. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total transaction of $969,900.00. Following the completion of the sale, the director now owns 76,058 shares of the company’s stock, valued at approximately $14,753,730.84. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 76,174 shares of company stock worth $14,981,909. Company insiders own 0.89% of the company’s stock.
A number of large investors have recently added to or reduced their stakes in UNH. Patriot Financial Group Insurance Agency LLC grew its stake in shares of UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after buying an additional 603 shares in the last quarter. Blue Chip Partners Inc. purchased a new stake in shares of UnitedHealth Group in the 2nd quarter valued at $110,000. Kings Point Capital Management raised its holdings in shares of UnitedHealth Group by 27.9% in the 1st quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 150 shares during the period. Bruderman Asset Management LLC purchased a new stake in shares of UnitedHealth Group in the 2nd quarter valued at $114,000. Finally, Mitsubishi UFJ Securities Holdings Co. Ltd. raised its holdings in shares of UnitedHealth Group by 433.3% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after buying an additional 520 shares during the period. Institutional investors own 86.19% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “Investors Sell UnitedHealth Group Incorporated (UNH) on Strength (UNH)” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright & trademark law. The original version of this story can be accessed at https://www.thecerbatgem.com/2017/10/03/investors-sell-unitedhealth-group-incorporated-unh-on-strength-unh.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.